Skip to content
Use caution Drug recall · FDA · Published January 7, 2013

West-Ward Recalls Glycopyrrolate Tablets Due to Subpotency

West-Ward recalls 1,185 bottles of 1 mg Glycopyrrolate tablets (Lot 69001A) due to subpotent drug issues. Check your medication immediately.

🇺🇸 FDA recall #D-164-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

What happened, in plain English

West-Ward Pharmaceutical Corp. is recalling one lot of Glycopyrrolate Tablets, USP, 1 mg because the drug is subpotent. The affected product consists of 1,185 bottles distributed in Ohio. A subpotent drug may not provide the intended therapeutic effect. Read more at govinfonow.com/recall/48421-west-ward-pharmaceutical-corp-recalls-glycopyrrolate-tablets-usp-1-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/48421-west-ward-pharmaceutical-corp-recalls-glycopyrrolate-tablets-usp-1-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-164-2013

Cite this page

“West-Ward Recalls Glycopyrrolate Tablets Due to Subpotency.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48421-west-ward-pharmaceutical-corp-recalls-glycopyrrolate-tablets-usp-1-mg. Based on FDA recall #D-164-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-164-2013%22&limit=1).

Why it’s dangerous

The tablets are classified as subpotent, meaning they contain less of the active ingredient than labeled. This can result in the medication failing to treat the condition it was prescribed for effectively.

Who’s affected

Patients in Ohio who have been prescribed or possess Glycopyrrolate Tablets, USP, 1 mg from the specific lot identified in this recall are affected. These individuals rely on the medication for its intended medical use.

How to tell if you have this one

Check your bottle for the National Drug Code (NDC) 0143-1250-01 and Lot Number 69001A. The product is manufactured by West-Ward Pharmaceutical Corp. in Eatontown, NJ, and contains 100 tablets per bottle.

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Pharmacist

    Reach out to your pharmacy or healthcare provider to discuss the recall and determine if you have the affected lot.

  2. Verify Lot Number

    Inspect your medication bottle for NDC 0143-1250-01 and Lot #69001A to confirm if it is part of this recall.

Where it went and when

Where it was distributed

Distributed in Ohio.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “OH” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Ohio.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Jan 7, 201312. FDA classified it Class III: Feb 12, 201323. Published in FDA’s Enforcement Report: Feb 20, 201334. FDA terminated the recall: May 16, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-164-2013 (January 7, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-164-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA